Loading data for PRENW — first visit, this takes a few seconds.
Prenetics Global Limited (PRENW)
NasdaqCM: PRENW
· Echtzeitkurs · USD
0.01
+0.00 (0.00%)
Zum Schluss: Aug 13, 2026, 2:31 PM
Prenetics Global Limited (PRENW) Stock Price, Analysis & Data
0.00% (1D)
Keine Daten verfügbar
| Geld | n/a |
| Marktkapitalisierung | n/a |
| Umsatz (TTM) | 120.07 Mio |
| Nettogewinn (TTM) | -55.87 Mio |
| Beta | 0.25 |
| EPS (ttm) | -11.04 |
| KGV (TTM) | n/a |
| Forward-KGV | n/a |
| KBV (TTM) | n/a |
| KUV (TTM) | n/a |
| Earnings Date | n/a |
| Brief | n/a |
| Volumen | 5 |
| Ø Vol. (20D) | |
| Eröffnung | 0.02 |
| Vortagesschluss | 0.01 |
| Tagesspanne | 0.01 - 0.01 |
| 52-Wk Range | 0.01 - 0.01 |
| Analyst | n/a |
| Kursziel | n/a |
| Dividenden | n/a |
| Ex-Dividenden-Datum | n/a |
Über PRENW
Prenetics Global Limited operates as a consumer health sciences company in the United States and Hong Kong. The company focuses on advancing human health and longevity through science-backed products under the IM8 brand. It also operates a consumer genetic testing brand in CircleDNA leveraging sequencing technology to deliver personalized reports across various categories. The company was founded in 2014 and is headquartered in Quarry Bay, Hong K...
IPO Datum Jul 17, 2026
Mitarbeiter 98
Börse NasdaqCM
Tickersymbol PRENW
Website https://www.prenetics.com
Finanzielle Entwicklung
Im Jahr 2025 betrug der Umsatz von Prenetics Global 92.39 Mio, ein Anstieg von 479.76% im Vergleich zum Vorjahr (15.94 Mio). Der Gewinn lag bei -37.71 Mio, ein Rückgang von -18.56 %.
Finanzberichte
Seite 1 von 2